Nutex Health (NASDAQ:NUTX) Trading Down 6.4% – Here’s What Happened

Nutex Health Inc. (NASDAQ:NUTX)’s share price was down 6.4% during trading on Thursday . The stock traded as low as $102.03 and last traded at $101.9950. Approximately 419,867 shares changed hands during mid-day trading, an increase of 108% from the average daily volume of 201,798 shares. The stock had previously closed at $109.00.

Analysts Set New Price Targets

Several analysts have recently commented on NUTX shares. Weiss Ratings reissued a “hold (c)” rating on shares of Nutex Health in a research note on Friday, March 27th. Wall Street Zen downgraded Nutex Health from a “strong-buy” rating to a “hold” rating in a research note on Saturday, March 7th. Two analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $252.50.

Nutex Health Stock Down 6.4%

The company has a quick ratio of 3.39, a current ratio of 3.41 and a debt-to-equity ratio of 0.70. The stock has a 50-day simple moving average of $100.59 and a 200-day simple moving average of $126.02. The firm has a market capitalization of $710.53 million, a PE ratio of 11.34 and a beta of 0.10.

Nutex Health (NASDAQ:NUTX) last released its earnings results on Thursday, March 5th. The company reported $1.61 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $5.56 by ($3.95). Nutex Health had a return on equity of 17.67% and a net margin of 7.34%.The firm had revenue of $151.68 million during the quarter, compared to analysts’ expectations of $258.82 million.

Institutional Trading of Nutex Health

A number of large investors have recently bought and sold shares of NUTX. Bank of America Corp DE increased its position in Nutex Health by 6,590.3% in the fourth quarter. Bank of America Corp DE now owns 2,074 shares of the company’s stock worth $66,000 after buying an additional 2,043 shares during the last quarter. Goldman Sachs Group Inc. increased its position in Nutex Health by 17.9% in the first quarter. Goldman Sachs Group Inc. now owns 18,119 shares of the company’s stock worth $852,000 after buying an additional 2,748 shares during the last quarter. Jane Street Group LLC purchased a new stake in Nutex Health in the first quarter worth $522,000. JPMorgan Chase & Co. increased its position in Nutex Health by 41,430.0% in the second quarter. JPMorgan Chase & Co. now owns 8,306 shares of the company’s stock worth $1,034,000 after buying an additional 8,286 shares during the last quarter. Finally, Legal & General Group Plc purchased a new stake in Nutex Health in the second quarter worth $454,000. 5.32% of the stock is owned by hedge funds and other institutional investors.

About Nutex Health

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.